Lu Kang Pharmaceutical: Received the approval notice for the supplementary application of Amikacin Sulfate Injection.

On August 7, Lu Kang Pharmaceutical announced that its holding subsidiary, Saiter Company, received the "Notice of Approval for Supplementary Drug Application" issued by the National Medical Products Administration regarding Amikacin Sulfate Injection.